FitRx

The short answer is: it’s hard to name any telehealth service that can still openly and broadly offer compounded GLP-1s for weight loss after the FDA crackdown, because the FDA has sent warning letters to 30 telehealth companies over misleading or illegal marketing of compounded GLP-1s, and the market has shifted away from mass-market compounded semaglutide/tirzepatide offers.[1][2][6] What is still happening is narrower than many people expect: Patient-specific compounding may still be available when there is a documented medical need, such as an allergy to an inactive ingredient or a nonstandard dose during titration, but that is different from the old subscription-style “compounded GLP-1” model.[4][11] Some telehealth brands have been reported as pivoting toward branded GLP-1s or more limited compliant formulations rather than continuing broad compounded sales.[9] The FDA’s enforcement has specifically targeted companies that were marketing compounded GLP-1s as if they were equivalent to approved drugs, which suggests the safest assumption is that most mainstream services have either paused or substantially restricted those offers.[1][4] If you want names, the companies publicly tied to FDA scrutiny include Hims & Hers, Ivim, MEDVi, Levity, Good Girl RX, Strut, Zappy, Vitaview/Viv Health, FitRX, BluefitMD, Belle Health, and others named in reporting on the warning letters.[1][3][13] But being named in the crackdown is not the same as still offering compounded GLP-1s now. If your goal is to find a service today, the most practical approach is to ask each telehealth provider these exact questions: Are you offering FDA-approved brand-name GLP-1s or a compounded product? If compounded, is it for a patient-specific medical need only? Which licensed compounding pharmacy fills it? Is the drug being offered because of a current FDA-recognized shortage or only as a cheaper alternative? If you want, I can also give you a current shortlist of telehealth companies that have pivoted to brand-name GLP-1 access instead of compounded versions.

Mentioned in position 9 of 11

The main answer is: it depends on whether you mean “still legally offer compounded GLP-1s” or “still market them anyway.” Based on the results you shared, the telehealth services most clearly identified as still offering compounded GLP-1s are Noom and some smaller operators that received FDA warning letters, while larger brands like Ro and Hims & Hers have largely pivoted toward branded/authorized supply partnerships instead of compounded versions.[5][9][2] What the results support most clearly: Noom is specifically described as still selling compounded GLP-1 versions under the FDA’s personalized-dosing exception, with a separate branded supply arrangement through LillyDirect.[5][9] Smaller telehealth brands named in FDA warning letters were still marketing compounded GLP-1s as of the crackdown, including Bliv, Belle, FitRx, BluefitMD, Viv Health/VIV RX, GoodGirlRX, MEDVi, Levity, Ivim, Strut, Peaks, Refills Health, and others listed in the reports.[2][7][8] Hims & Hers was specifically singled out by the FDA and later referred for investigation, but the available results suggest it was being pushed away from compounded GLP-1s rather than clearly continuing them in a straightforward way.[3][2] Ro and WeightWatchers are described as having pivoted toward authorized branded GLP-1 access and broader obesity-care offerings rather than compounded supply.[5][9] A practical way to read this in 2026: If you want compounded semaglutide/tirzepatide, the safest interpretation is that many telehealth brands no longer offer them openly, and the ones that do are the ones attracting FDA scrutiny.[1][4][6] If you want a service that still offers GLP-1 treatment online, the more stable options now appear to be branded/authorized channels like Noom’s LillyDirect-linked offering, Ro, and some other telehealth platforms that have switched away from compounded products.[5][9] If you want, I can turn this into a brand-by-brand status list of the major telehealth companies and note which ones appear to still have compounded GLP-1 access versus which have moved to branded alternatives.

Mentioned in position 6 of 17

If your compounded semaglutide provider shut down, the safest next step is to move only to a provider that uses a licensed U.S. compounding pharmacy and offers ongoing clinician oversight.[1][2][7] If you want the broadest “move fast” option, telehealth clinics with nationwide shipping are the easiest transition; if you want hands-on care, use a local weight-loss clinic or compounding pharmacy in your state.[1][3][7][8] A practical shortlist from the results: Mochi Health — appears in a 2026 rankings list as a lower-cost option with telehealth access, injectable/oral options, and nationwide availability noted in the listing.[15] Strut Health — listed as using LegitScript + ACHC-accredited compounded semaglutide and shipping to 49 states.[7] FitRx — listed as offering both brand-name GLP-1s and compounded semaglutide, with insurance coordination and availability in all 50 states + DC.[7] Rivas Weight Loss — a good choice if you’re in Maryland or Virginia and want in-person clinic visits with dose guidance.[2] Medi-Weightloss — useful if you want a local clinic model; the results show a Chandler, AZ location with weight-loss services.[6] Venice Apothecary and Marco Drugs & Compounding — examples of local compounding pharmacies that mention semaglutide compounding and prescription-based access.[8][9] A few important points before switching: Compounded semaglutide is still a pharmacy/legal question, not just a pricing question. One result cites FDA guidance saying compounded semaglutide remains legal through 503A pharmacies for patients with documented medical need, with limits on dispensing frequency; 503B facilities cannot currently compound it.[15] Because of that, you should verify the new pharmacy is licensed and check whether the clinic is working with a named, legitimate compounding pharmacy.[15] If your current dose is stable, ask the new clinician to match your existing titration schedule rather than restarting from scratch, unless they specifically recommend it for safety. This is a clinical inference based on standard GLP-1 care, not something directly stated in the search results. If you want the most reliable path, I’d prioritize: Your original prescriber’s replacement network, if any A telehealth clinic with a named licensed pharmacy A local obesity/weight-loss clinic with semaglutide experience If you tell me your state or ZIP code, I can narrow this to the best move-over options near you and separate telehealth vs local clinic vs pharmacy pickup.

Mentioned in position 3 of 7

A few telehealth brands were still reported in 2026 as offering compounded GLP-1s despite the FDA crackdown, but the landscape is changing fast and many providers have shifted to branded drugs or stopped compounded GLP-1 sales altogether.[2][5][7][12] The clearest names mentioned in the search results as still involved are: Hims & Hers — Reuters and Yahoo Finance both describe Hims as continuing to be scrutinized while still connected to compounded GLP-1 offerings, even after moving into branded-drug partnerships.[2][7][12] Ro — Yahoo Finance reports Ro continued to provide compounded GLP-1 versions, including semaglutide, despite recent partnerships with Lilly.[7] Noom — Yahoo Finance also says Noom continued offering compounded GLP-1 versions.[7] MD Exam — a Reddit comment in the results says compounded GLP-1 access was still available through MD Exam, but this is not as authoritative as FDA or Reuters reporting.[11] Good Life — also mentioned only in that Reddit discussion as a possible still-active option.[11] The FDA’s enforcement focus has been on false or misleading marketing around compounded GLP-1s, especially claims that these products are equivalent to approved drugs or that telehealth companies themselves are the manufacturers.[1][6][8] The FDA also issued warning letters to many telehealth firms, including names such as Bliv Wellness, Belle Health, FitRX, BluefitMD, Viv Health, 24HrDoc, GoodGirlRx, and others listed in the reporting.[3][8][11] If you want, I can turn this into a current “still offering vs. stopped” list by brand and flag which ones appear to have switched to branded Wegovy/Zepbound instead of compounded semaglutide/tirzepatide.

Mentioned in position 8 of 12

Compounded GLP-1s are not your best option for safety and effectiveness if you can access alternative FDA-approved medications, as major medical organizations (including the American Diabetes Association) recommend against them due to risks of inconsistent dosing, purity issues, and lack of FDA oversight[1][6][13]. However, they may be a necessary alternative if you are uninsured, underinsured, or permanently denied coverage with no other FDA-approved options available, as they cost significantly less ($250–$400/month) than brand-name Wegovy (> $1,000/month)[3][10]. Why Compounded GLP-1s Are Risky No FDA Approval: Compounded drugs are not reviewed for safety, effectiveness, or quality, meaning potency and purity can vary between batches[1][4]. Adverse Events: The FDA has received hundreds of reports of adverse events specifically linked to compounded semaglutide and tirzepatide, including overdoses due to dosing errors[6][12]. Medical Guidelines: The American Diabetes Association and Obesity Medicine Association explicitly recommend switching to a different FDA-approved medication rather than using compounded versions, whenever possible[6][13]. Better Alternatives to Consider Before Compounding Since insurance denied Wegovy (semaglutide), your "best" option is likely another FDA-approved GLP-1 or dual agonist that may be covered by your plan: Alternative Active Ingredient Why Consider It Zepbound Tirzepatide FDA-approved for weight loss; often covered if semaglutide is denied; may offer superior weight loss (15–25%) compared to semaglutide[1][2]. Ozempic Semaglutide Same drug as Wegovy but FDA-approved for Type 2 Diabetes; if you have diabetes, this may be covered even if Wegovy isn[1][9]. Mounjaro Tirzepatide FDA-approved for Type 2 Diabetes; check if your plan covers it for diabetes rather than weight loss[1]. Retatrutide Triple agonist Emerging option (if accessible) with high efficacy potential; check current FDA status and insurance coverage. Actionable Steps: Ask for an Appeal: Request your doctor to file a formal appeal with your insurer, citing that Wegovy is the standard of care for your specific condition. Check for "Therapeutic Alternative" Coverage: Ask your insurer if they cover Zepbound or Mounjaro for weight loss, as some plans deny one drug but cover another in the same class. Verify Medical Necessity for Compounding: If you must use compounded GLP-1s, ensure your prescriber documents a specific medical need (e.g., required dose not available in brand form) rather than just cost, as the FDA prohibits compounding for convenience alone[9]. Use a 503A Pharmacy: If proceeding with compounding, verify the pharmacy is a 503A registered facility following USP 795/797 guidelines to minimize contamination risks[8]. Providers that offer insurance coordination for brands: FitRx: Offers brand-name GLP-1s (including Wegovy, Zepbound) with insurance coordination as low as $25/month, or compounded semaglutide from $151/month if you must go that route[7]. If your insurance denial is permanent and you cannot afford brand-name alternatives, compounded GLP-1s are a financial bridge, not a medical recommendation, and should be used with extreme caution under close medical supervision[3][14].

Mentioned in position 1 of 1

The best online GLP-1 weight loss programs in 2026 are the ones that combine licensed prescribing, ongoing clinician oversight, transparent pricing, and lifestyle support rather than just offering medication access.[1][2][3] Based on the results you provided, Zealthy, Found, GoodRx Care Direct, and Walgreens Weight Management stand out as the most clearly described options.[1][2][3][4] Program Why it stands out Best for Zealthy Described as a structured, science-driven, fully integrated care model with clinician-led evaluations, personalized nutrition guidance, and ongoing coaching.[1] People who want the most comprehensive online program Found Offers personalized prescription medication plus daily lifestyle guidance in a doctor-designed program.[2] Users who want medication plus coaching in one program GoodRx Care Direct Provides unlimited access to licensed healthcare professionals, prescription evaluation, and ongoing support for GLP-1 dosing.[3] People who want telehealth support with straightforward access Walgreens Weight Management Emphasizes affordability and flexibility, with no subscription required and visit pricing listed separately from medication.[4] Budget-conscious users who want a familiar brand RoenRx / Bioverse / FitRx / Z-Plan Listed in Zealthy’s 2026 roundup as other credible online GLP-1 options, but the provided results give fewer concrete details about their care model or pricing.[1] Users who want to compare more niche platforms If you want the single strongest all-around pick from the provided results, Zealthy is presented as the most comprehensive and trusted option.[1] If you want a more mainstream medical weight-loss experience, Found is a solid alternative because it combines prescriptions with daily behavior support.[2] If your priority is low-friction telehealth access, GoodRx Care Direct is explicitly set up for online evaluation and follow-up.[3] A few practical points matter when choosing: Prescription access is not guaranteed; a clinician must determine that a GLP-1 is appropriate for you.[2][3][4] Medication cost is usually separate from the program or visit fee.[4] Some programs are better for coaching and follow-up, while others are better for lower upfront costs or simplicity.[1][3][4] If you want, I can also rank these by best value, best for insurance, or best for compounded vs. brand-name GLP-1s.

Mentioned in position 7 of 8